BP-C1

DRUG6 trials

Sponsors

Meabco A/S

Conditions

Metastatic Breast CancerMetastatic Pancreatic CancerStage IV Breast CancerUnresectable Pancreatic Cancer

Phase 1

BP-C1 in Metastatic Breast Cancer Patients

CompletedNCT01861509

Meabco A/SMetastatic Breast Cancer, Stage IV Breast Cancer

Start: 2014-01-19End: 2016-01-20Updated: 2019-10-07

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

CompletedNCT04298333

Meabco A/SMetastatic Breast Cancer, Stage IV Breast Cancer

Start: 2009-06-27End: 2011-01-04Updated: 2020-03-06

Phase 2

BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

CompletedNCT02783794

Meabco A/SMetastatic Breast Cancer, Stage IV Breast Cancer

Start: 2012-12-24End: 2014-02-28Updated: 2019-10-10

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

CompletedNCT03603197

Meabco A/SMetastatic Breast Cancer, Stage IV Breast Cancer

Start: 2014-06-05End: 2016-08-30Updated: 2019-10-07

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

CompletedNCT03627390

Meabco A/SMetastatic Pancreatic Cancer, Unresectable Pancreatic Cancer

Start: 2014-12-19End: 2016-03-04Updated: 2018-11-15

BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment

CompletedNCT03789019

Meabco A/SMetastatic Breast Cancer, Stage IV Breast Cancer

Start: 2013-02-22End: 2016-07-29Updated: 2019-10-10

Related Papers

BP-C1 in treatment of pretreated metastatic breast cancer: A meta-analysis of two randomized, double-blind and placebo-controlled multicenter studies.

Journal of Global Oncology2019-10-07

Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

Breast Cancer Targets and Therapy2019-01-017 citations